Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

BACKGROUND: Waldenström macroglobulinemia (WM) is preceded by asymptomatic WM (AWM), for which the risk of progression to overt disease is not well defined. METHODS: We studied 439 patients with AWM, who were diagnosed and observed at Dana-Farber Cancer Institute between 1992 and 2014. RESULTS: Duri...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Bustoros, Mark, Sklavenitis-Pistofidis, Romanos, Kapoor, Prashant, Liu, Chia-Jen, Kastritis, Efstathios, Zanwar, Saurabh, Fell, Geoffrey, Abeykoon, Jithma P., Hornburg, Kalvis, Neuse, Carl Jannes, Marinac, Catherine R., Liu, David, Soiffer, Jenny, Gavriatopoulou, Maria, Boehner, Cody, Cappuccio, Joseph M., Dumke, Henry, Reyes, Kaitlen, Soiffer, Robert J., Kyle, Robert A., Treon, Steven P., Castillo, Jorge J., Dimopoulos, Meletios A., Ansell, Stephen M., Trippa, Lorenzo, Ghobrial, Irene M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2019
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544461/
https://ncbi.nlm.nih.gov/pubmed/30990729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00394
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg